Qin Su

Targeting intracellular immune regulatory molecules for cancer immunotherapy in solid tumors.

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but remain limited by primary and acquired resistance, highlighting the need for novel immunotherapeutic strategies beyond cell-surface receptors. Intracellular immune regulators integrate signaling downstream of immune receptors and therefore represen...

Germline EGFR T790M mutation and lung cancer risk.